Share This Article
Most weight loss programs hand everyone the same plan. Eat less, move more, track your calories, and hope for the best. Found takes a different approach. It is a medically guided weight care platform that pairs members with clinicians trained in obesity medicine, prescribes from a toolkit of over ten medications based on individual health profiles, and provides ongoing support to help people achieve results that actually last. With over 300,000 members served and 1.4 million pounds lost, the outcomes speak to an approach that is working where generic programs have not.
Why Generic Weight Loss Programs Fall Short
Weight is not simply a willpower problem. Hormones, metabolism, genetics, sleep quality, stress levels, and other biological factors all play a role in how the body stores and burns fat. A program that ignores this complexity and hands everyone the same meal plan and exercise routine is not addressing the actual biology at work.
Found was built around the recognition that lasting weight loss requires treating the biological side of the equation directly, with medically prescribed treatments matched to the individual, alongside the behavioural support that helps people build sustainable habits. It is the combination of both that produces the kind of results members report, not one or the other in isolation.
How the Program Works
The process starts with a health assessment that captures a detailed picture of each member’s health history, current medications, weight goals, and lifestyle. A clinician trained in obesity medicine reviews that profile and, if eligible, prescribes a medication plan tailored to the individual’s biology and circumstances.
Medication is shipped to the member’s door. Most people can begin treatment within a week of completing their assessment. The care does not stop at the first prescription. Monthly check-ins with a provider allow the plan to be adjusted as the member’s body responds and progress is tracked. Support is available between visits for any questions or concerns that come up along the way. More than 80 percent of Found members report zero side effects when starting their medication, which reflects the advantage of individualised dosing over a one-size-fits-all approach.
A Medication Toolkit That Matches the Person
One of the most significant differences between Found and most telehealth weight loss services is the breadth of its medication options. Rather than offering a single drug and fitting everyone to it, Found-affiliated clinicians can choose from over ten different medications to personalise each member’s treatment plan.
The range includes compounded semaglutide and compounded tirzepatide, brand-name GLP-1 medications including Wegovy, Ozempic, Zepbound, and Mounjaro, Saxenda and Victoza for liraglutide-based treatment, Metformin, Contrave, Topiramate, Zonisamide, and Foundayo, the brand’s own orforglipron-based medication. Having this range available means clinicians can consider a member’s specific health history, sensitivities, budget, and insurance situation when selecting a treatment, rather than defaulting to whatever a single-option platform offers.
Clinical trials for Wegovy and Zepbound, the highest-dose GLP-1 medications, showed average weight loss of 15 and 20 percent respectively over 68 to 72 weeks when combined with lifestyle changes, compared to 2 to 3 percent with lifestyle changes alone. For members who qualify for these medications, those are meaningful numbers.
The GLP-1 Microdosing Program
For those who want a gentler introduction to GLP-1 medications, Found offers a dedicated microdosing program. It is designed as a simpler entry point, using lower initial doses to allow the body to adjust gradually. The program suits members who may have concerns about side effects or who prefer a slower start before titrating to a standard dose. It is one of the more practical approaches to managing the early adjustment period that some people experience with GLP-1 medications.
Found is one of the only telehealth weight care providers partnering with major insurance carriers across the United States to make care more affordable. Coverage is available in the majority of US states, and accepted plans include United Healthcare, Aetna, Blue Cross Blue Shield, Cigna, Anthem, and others depending on state.
For the roughly one in three Americans whose insurance covers the program, copays for visits can be under thirty dollars. For those without coverage, self-pay membership options are available with transparent pricing that includes clinical care. Medication costs vary separately depending on the type prescribed and whether insurance covers it.
What the Results Look Like
The member outcomes on the platform reflect what medically guided, personalised weight care can achieve. Found members lost an average of 12 percent of body weight over one year based on data from members who tracked their weight consistently. Eighty-three percent of members sustain their results for a full year, which addresses the most common failure point of weight loss programs: the weight coming back.
Beyond the scale, members report improvements in conditions that accompany excess weight. Sleep apnea resolved for members like Jessica, who lost 120 pounds. Others note improvements in blood pressure, cholesterol, joint pain, energy levels, and mental health. These outcomes reflect what happens when the biology of weight is treated seriously rather than treated as a side effect of not trying hard enough.
More Than a Prescription Service
Found combines its clinical program with in-app tracking tools, a behaviour change program developed by experts, and a community of members who share the same journey. The behavioural side of weight management matters alongside the biological, and Found addresses both rather than treating the medication as the only lever.
For anyone who has tried conventional approaches without achieving lasting results, or who wants access to medically guided weight care without waiting months for an in-person specialist appointment, Found offers a credible, accessible, and clinically supported alternative.
